Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1. (Q34135435)

31 July 2017

1 reference

title

Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1. (English)

1 reference

31 July 2017

Tamás Hegedus

1

1 reference

31 July 2017

László Orfi

2

1 reference

31 July 2017

Attila Seprodi

3

1 reference

31 July 2017

András Váradi

4

1 reference

31 July 2017

Balázs Sarkadi

5

1 reference

31 July 2017

György Kéri

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Biochimica et Biophysica Acta

31 July 2017

published in

1 reference

31 July 2017

volume

1587

1 reference

31 July 2017

issue

2-3

1 reference

31 July 2017

page(s)

318-325

1 reference

Molecular mechanisms underlying ErbB2/HER2 action in breast cancer

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Chronic myelogenous leukaemia--new therapeutic principles.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

STI571 revolution: can the newer targeted drugs measure up?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Combinatorial chemoprevention of intestinal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Comparative analysis of somatostatin analog peptides by capillary electrophoresis and micellar elektrokinetic chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Multidrug resistance in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

The multidrug resistance protein family.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Pharmacological considerations in the modulation of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Calcein accumulation as a fluorometric functional assay of the multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Atom/fragment contribution method for estimating octanol-water partition coefficients.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Signal-transduction therapy. A novel approach to disease management

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Protein tyrosine kinase inhibitors as novel therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Protein tyrosine kinases and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Tyrphostin induces non-apoptotic programmed cell death in colon tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Gene therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

Interaction of bioactive hydrophobic peptides with the human multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900095-9

7 January 2021

10.1016/S0925-4439(02)00095-9

Identifiers

DOI

1 reference

31 July 2017

1 reference